Wij zijn onze website aan het vernieuwen.

Ontdekt u nog een pagina die niet klopt of hebt u een goede suggestie, laat het ons dan weten via webmedia@umcutrecht.nl.

Deze website maakt gebruik van cookies

Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Lees meer over het cookiebeleid.

dr. ir. B.H.M. (Bas) van der Velden Researcher/Postdoc

  • Image Sciences Institute

B.H.M. van der Velden

Contact

Biography

Bas van der Velden (1986) is a postdoctoral researcher at the University Medical Center Utrecht. He received his PhD in Medical Imaging at Utrecht University and his MSc degree in Medical Engineering at the Eindhoven University of Technology. He has experience at research labs in the USA (UC Berkeley and Memorial Sloan Kettering Cancer Center).

Bas’s research focuses on breast cancer prognosis and personalized treatment using medical image analysis and machine learning.

Research Output (17)

Are contralateral parenchymal enhancement on dynamic contrast-enhanced MRI and genomic ER-pathway activity in ER-positive/HER2-negative breast cancer related?

van der Velden Bas H M, Bismeijer Tycho, Canisius Sander, Loo Claudette E, Lips Esther H, Wesseling Jelle, Viergever Max A, Wessels Lodewyk F A, Gilhuijs Kenneth G A 16 okt 2019, In: European Journal of Radiology. 121

Response monitoring of breast cancer on DCE-MRI using convolutional neural network-generated seed points and constrained volume growing

van der Velden BHM, de Vos Bob D., Loo Claudette E., Kuijf HJ, Isgum I, Gilhuijs KG 2019, 10950

Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients

van der Velden BHM, Sutton Elizabeth, Carbonaro Luca, Pijnappel Ruud, Morris Elizabeth, Gilhuijs Kenneth nov 2018, In: European Radiology. 28 , p. 4705-4716

Perfusion in the contralateral breast on preoperative MRI may complement ER-pathway activity from the index tumor to stratify outcome of endocrine therapy for early-stage invasive breast cancer

Van der Velden B., Bismeijer T., Canisius S., Loo C., Lips E., Wesseling J., Viergever M., Wessels L., Gilhuijs K. apr 2018, In: European Journal of Cancer. 92 , p. S49-S50

Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle

Merckel LG, Verburg Erik, van der Velden Bas H M, Loo Claudette E., van den Bosch Maurice A A J, Gilhuijs Kenneth G A 2018, In: The Breast Journal. 24 , p. 501-508

Analysis of healthy breast tissue on MRI for prognosis of breast cancer

van der Velden B.H.M. 21 dec 2017, 143 p.

Complementary value of contralateral parenchymal enhancement on DCE-MRI to prognostic models and molecular assays in high-risk ER+HER2- breast cancer

van der Velden Bas H M, Elias Sjoerd G, Bismeijer Tycho, Loo Claudette E., Viergever Max A, Wessels Lodewyk F A, Gilhuijs Kenneth G A 2017, In: Clinical Cancer Research. 23 , p. 6505-6515 11 p.

Eigentumors for prediction of treatment failure in patients with early-stage breast cancer using dynamic contrast-enhanced MRI:a feasibility study

Chan HM, van der Velden Bas H M, Loo Claudette E., Gilhuijs Kenneth G A 2017, In: Physics in Medicine and Biology. 62 , p. 6467-6485

Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast Cancer

Knuttel Floortje M., van der Velden Bas H M, Loo Claudette E, Elias Sjoerd G, Wesseling Jelle, van den Bosch Maurice A A J, Gilhuijs Kenneth G A jul 2016, In: Investigative Radiology. 51 , p. 462-468 7 p.

Determining the bias and variance of a deterministic finger-tracking algorithm

Morash Valerie S., van der Velden Bas H M jun 2016, In: Behavior Research Methods. 48 , p. 772-782 11 p.

All Research Output (17)
To top